Today we announced positive preliminary immunogenicity data
Sanatate
Today we announced positive preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE® (COVID-19 Vaccine, mRNA), which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. Learn more: https://t.co/9V7geryiOy. https://t.co/F3RO6urdxm
din zilele anterioare